You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 21, 2025

Details for Patent: 9,925,268


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,925,268 protect, and when does it expire?

Patent 9,925,268 protects UZEDY and is included in one NDA.

This patent has twenty-eight patent family members in eight countries.

Summary for Patent: 9,925,268
Title:Drug-containing implants and methods of use thereof
Abstract:The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.
Inventor(s):Siegel Steven, Winey Karen
Assignee:THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Application Number:US15627349
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,925,268: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the details of United States Patent 9,925,268, exploring its claims, scope, and the broader patent landscape it inhabits.

Overview of the Patent

United States Patent 9,925,268, hereafter referred to as the '268 patent, is a utility patent granted by the U.S. Patent and Trademark Office (USPTO). To analyze this patent, one must first identify the key elements such as the invention's description, claims, and any relevant prior art.

Invention Description

The '268 patent describes a specific invention, which could be a product, process, or method. For instance, if the patent pertains to a pharmaceutical, it would detail the composition, formulation, and any unique aspects of the drug. Understanding the invention's description is essential for grasping the patent's scope and claims.

Claims Analysis

Independent and Dependent Claims

Patent claims are the most critical part of a patent application, as they define the scope of protection. The '268 patent will include both independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims and provide more specific details[3].

Claim Scope and Concepts

Each claim in the '268 patent will be categorized based on its scope and concepts. This categorization helps in understanding which aspects of the invention are protected and where gaps or opportunities might exist. For example, if the patent is related to a drug, the claims might cover specific formulations, dosages, or methods of administration[3].

Patent Landscape

Related Patents and Prior Art

The '268 patent is part of a larger patent landscape that includes related patents and prior art. Analyzing these elements helps in understanding the patent's position and potential vulnerabilities. For instance, if there are other patents in the same family or from the same inventors, these could impact the '268 patent's validity or scope[1].

Continuations and Continuations-in-Part

Patents can be part of a family that includes continuations and continuations-in-part. These relationships can affect the patent term and the scope of protection. For example, if the '268 patent is a continuation-in-part of an earlier patent, it may claim priority from that earlier patent, which could influence its expiration date and any potential obviousness-type double patenting (ODP) issues[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration when analyzing patents within the same family. If multiple patents claim the same invention or obvious variants thereof, they may be subject to ODP, which could invalidate some or all of the claims. This was a key issue in the case of In re Cellect LLC, where multiple patents were invalidated due to ODP[1].

Patent Term and Adjustments

The term of the '268 patent is another important aspect. Patents typically have a term of 20 years from the filing date of the earliest non-provisional application to which they claim priority. However, this term can be adjusted due to delays in the USPTO's processing, known as Patent Term Adjustment (PTA)[1].

Claim Coverage Matrix and Scope Concepts

To effectively analyze the '268 patent, a Claim Coverage Matrix can be used. This matrix categorizes patents and claims by their scope concepts, making it easier to identify which claims are actively protecting the intellectual property and where gaps or opportunities exist. This approach helps in filtering, searching, and analyzing large numbers of patent claims concurrently[3].

Practical Applications and Future Directions

Claim Charts and Technical Review

Interactive claim charts generated from tools like ClaimScape® can be reviewed by technical experts to determine whether specific scope concepts are applicable to target products or methods. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

Value Assessment

The scope concepts of the patent claims can be assessed for their value to the company. Claims can be categorized as high-value (currently crucial), medium-value (potential future direction), or low-value (perhaps not worth maintaining). This assessment is vital for strategic decision-making regarding patent maintenance and future development[3].

Regulatory and Legal Considerations

USPTO Guidelines

The USPTO provides guidelines and internal databases that are essential for understanding the patent application process and the final examination outcomes. These guidelines help in determining application characteristics, such as the origin of the application and whether it was filed by a large or small entity[4].

Court Precedents

Court decisions, such as Novartis AG v. Ezra Ventures LLC, provide important precedents on issues like ODP and Patent Term Extensions (PTE). These precedents can significantly impact the validity and scope of patents like the '268 patent[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of protection.
  • Patent Landscape: Analyzing related patents and prior art helps in positioning the '268 patent within the broader intellectual property landscape.
  • ODP Considerations: Ensuring that the patent does not fall under ODP is vital to maintain its validity.
  • Patent Term Adjustments: Understanding PTA and its impact on the patent term is essential.
  • Practical Applications: Using tools like Claim Coverage Matrix and claim charts to identify gaps and opportunities.

FAQs

What is the purpose of a Claim Coverage Matrix in patent analysis?

A Claim Coverage Matrix helps in categorizing patents and claims by their scope concepts, making it easier to identify which claims are actively protecting the intellectual property and where gaps or opportunities exist.

How does Obviousness-Type Double Patenting (ODP) affect patent validity?

ODP can invalidate patent claims if they are deemed obvious variants of earlier patents within the same family, as seen in the case of In re Cellect LLC[1].

What is the significance of Patent Term Adjustment (PTA) in patent term calculation?

PTA extends the patent term by the number of days the USPTO delayed in processing the patent application, ensuring that the patent holder receives the full term of protection[1].

How can interactive claim charts be used in patent analysis?

Interactive claim charts, generated from tools like ClaimScape®, help technical experts review patent coverage and identify gaps or future design opportunities[3].

What role do court precedents play in patent validity and scope?

Court precedents, such as Novartis AG v. Ezra Ventures LLC, provide important guidelines on issues like ODP and PTE, which can significantly impact the validity and scope of patents[1].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Analytics, Intellectual Property Law, Schwegman.
  4. What Is the Probability of Receiving a US Patent?, Yale Journal of Law and Technology.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,925,268

Showing 1 to 6 of 6 entries

International Family Members for US Patent 9,925,268

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2005206143 ⤷  Try for Free
Australia 2006269927 ⤷  Try for Free
Canada 2553254 ⤷  Try for Free
Canada 2614601 ⤷  Try for Free
China 101287423 ⤷  Try for Free
China 103637977 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.